Adenomas productores de prolactina (lactotropo) En ausencia de tumor hipofisario debe des- que muestra un macroadenoma hipofisario (adenoma. Manejo de pacientes con diagnóstico de adenoma hipofisario productor de prolactina. Experiencia del Hospital San José. Diana Cristina. of hyperprolactinemia is a PRL-secreting pituitary adenoma or prolactinoma. de un adenoma hipofisario productor de prolactina (PRL) o prolactinoma.

Author: Dugami Kigalkis
Country: Burundi
Language: English (Spanish)
Genre: Medical
Published (Last): 1 January 2009
Pages: 95
PDF File Size: 9.25 Mb
ePub File Size: 9.50 Mb
ISBN: 834-1-74617-361-3
Downloads: 15075
Price: Free* [*Free Regsitration Required]
Uploader: Nikinos

Aust N Z J Ophthalmol. Acta Neurochir Wien ; 7: Radiotherapy for prolactin-secreting pituitary tumors. Occult adenomas in the general population. Se describieron variables demogricas, clicas, seguimiento radiolico anual, prolactina PRL basal, a los 6 y 24 meses.

Se requieren estudios prospectivos para aclarar si la dosis acumulada es un factor predictor para aumentar el porcentaje de pacientes con retiro exitoso y establecer la mejor estrategia para retiro de agonistas de dopamina en pacientes con prolactinomas. Ben-Jonathan N, Hnasko R.

BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Trans Am Clin Climatol Assoc. A survey of British and American endocrinologists. Em segundo lugar, foi utilizada a porcentagem de macroprolactina para dar o valor real da prolactina. Eight patients met remission criteria.

Adenoma de hipófise

Pituitary magnetic resonance imaging in normal human volunteers. Ocho pacientes cumplieron criterios de remisi. Int J Clin Pract Dec;62 N Engl J Med. Pituitary Mar;15 1: Prolactinomas are the most common pituitary adenomas that affect young women prolacyina fertile age.


[Current diagnosis and treatment of hyperprolactinemia].

Hyperprolactinemia is a frequent neuroendocrinological condition that should be approached in an orderly and integral fashion, starting with a complete clinical history. Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment. For macroprolactinomas, the median treatment duration was 65 months and the median accumulated dose of cabergoline was mg. Prolactinomas resistant to standard doses of cabergoline: No primeiro estudo, Reincke e cols 2 avaliaram 18 tumores, 11 maiores que 10mm e 7 menores que 10mm.

Once physiological causes such as pregnancy, systemic disorders such as primary hypothyroidism and the use of drugs with dopamine antagonistic actions such as metochlopramide have been ruled out, the most common cause of hyperprolactinemia is a PRL-secreting pituitary adenoma or prolactinoma.

Demographic and clinical variables were described, as well as radiological monitoring once yearly and basal prolactin PRL measurements at 6 and 24 months. As for pregnancy, the drug of choice to induce ovulation still is bromocriptine.

[Current diagnosis and treatment of hyperprolactinemia].

Dopamine as a prolactin PRL inhibitor. A paciente deve ser monitorada clinicamente a cada trimestre. Nos macroprolactinomas, o manejo deve ser individualizado. Cabergoline Comparative Study Group. Donovan LE, Corenblum B.


Macroprolactina e incidentaloma hipofisário

Clinical treatment with dopamine agonists is the gold standard, with cabergoline as the first choice due to its greater efficiency and tolerability. Gostaria de perguntar sobre o papel da dosagem da subunidade a em incidentalomas? The incidentaloma of the pituitary gland. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition?

How to cite this article. Multiple endocrine neoplasia type 1. Clin Endocrinol ; A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

Macroprolactinomas can also present with symptoms and signs resulting form mass effect of the tumor, such as headaches and visual field defects. Management of pituitaty incidentalomas. Quality of life is decreased in female patients treated for microprolactinoma. Orphanet J Rare Dis. Size, shape and appearance of the normal female pituitary gland.

Colao A, Loche S.